AstraZeneca's Fasenra has been cleared for use by the NHS in England as an add-on treatment for the rare autoimmune disease ...

The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...

Improved patient outcomes and safety: Ultimately, smarter learning powered by AI should lead to better care. More ...

Returning for its third year, the Donor Selection & Cell Source Summit is the only industry-dedicated forum focused ...

Following the first-ever FDA approval of a TIL therapy in the U.S., and with regulatory decisions pending in Canada and ...

Vedanta is playing catch-up with VE303, as a rival microbiome therapy from Seres Therapeutics, called Vowst, has been ...

MSD's plan to reduce its headcount by around 6,000, first revealed a couple of weeks ago, looks like it will start at its ...

Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines ...

LEAP TA: Life Sciences is the only event entirely dedicated to transforming how biotech and pharma organizations are ...

The 9th MASH Drug Development Summit is the essential forum for pharmaceutical giants and innovative biotechs dedicated to ...

At Axtria Ignite 2025 in Princeton, New Jersey, editor-in-chief Jonah Comstock connected with GSK's SVP of enterprise AI and chief digital and technology officer, commercial, Madhavi Ramakrishna.

Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...